《半日速報》恆指跌219點; 恆生科技指數跌29點 藥明生物跌逾5% 重汽創新高
恆指半日收21,527點,跌219點或1.0%。恆生科技指數報4,477點,跌29點或0.6%。國指跌56點或0.8%,報7,294點。
活躍重磅股表現:
友邦(01299.HK) 收86.05元,下跌2.2%;
平安(02318.HK) 收59.5元,下跌2.1%;
港交所(00388.HK) 收357元,下跌1.8%;
美團(03690.HK) 收163.9元,下跌1%;
騰訊(00700.HK) 收367.2元,下跌0.8%;
阿里巴巴(09988.HK) 收113.9元,上升0.4%;
建行(00939.HK) 收5.1元,上升0.2%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收69.9元,下跌5.4%;
信義玻璃(00868.HK) 收16.86元,下跌4%;
國壽(02628.HK) 收14.38元,下跌3.5%;
申洲(02313.HK) 收99.5元,下跌3.4%;
創科(00669.HK) 收100.2元,下跌3.3%;
異動綜合中小型股:
先聲藥業(02096.HK) 收11.6元,下跌13.4%;
開拓藥業-B(09939.HK) 收10.3元,下跌13.2%;
榮暉國際(00990.HK) 收1.01元,上升12.2%;
沛嘉醫療(09996.HK) 收11.32元,下跌10%;
重汽(03808.HK) 收13.66元,上升2.2%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.